This study identified a novel differentially methylated region in the rhomboid 5 homolog 2 (RHBDF2) gene in ALS patients compared to controls, highlighting its potential as an epigenetic biomarker of neurodegeneration [62]. This evidence concerns the gene RHBDF2 and amyotrophic lateral sclerosis.